4.2 Review

Exploring m6A-RNA methylation as a potential therapeutic strategy for acute lung injury and acute respiratory distress syndrome

Related references

Note: Only part of the references are listed.
Review Immunology

The development of COVID-19 treatment

Yongliang Yuan et al.

Summary: The emergence of SARS-CoV-2 has led to the COVID-19 pandemic, which is the greatest global public health threat of this century. Recent studies have revealed many mysteries of SARS-CoV-2 pathogenesis, greatly enhancing the research on COVID-19 vaccines and therapies. However, significant questions remain regarding its treatment.

FRONTIERS IN IMMUNOLOGY (2023)

Review Pharmacology & Pharmacy

The role of RNA methyltransferase METTL3 in gynecologic cancers: Results and mechanisms

Yuxiang Zhang et al.

Summary: N6-methyladenosine (m6A) methylation, the most prevalent mRNA modification in eukaryotes, involves the methylation of nitrogen atoms on RNA adenine bases. Among the components of m6A methyltransferase, Mettl3 plays a crucial catalytic role in this process. Recent studies have shown that m6A is associated with various biological processes and significantly affects the progression and prognosis of gynecologic tumors, where the role of Mettl3 is important. Mettl3 is involved in multiple pathophysiological functions and may serve as a potential target for treating gynecologic malignancies, highlighting the need for further research on its role and mechanism.

FRONTIERS IN PHARMACOLOGY (2023)

Article Virology

Modulation of Covid-19 cytokine storm by tocilizumab

Alberto Boretti et al.

Summary: Covid-19, caused by the SARS-CoV-2 virus, was declared a global pandemic in March 2020. This study aims to investigate the role of IL inhibitors in Covid-19 treatment but conflicting results and recommendations still exist. Some countries include tocilizumab in treatment for cytokine storms, despite the contradictory findings in literature.

JOURNAL OF MEDICAL VIROLOGY (2022)

Review Biochemistry & Molecular Biology

m6A modification: recent advances, anticancer targeted drug discovery and beyond

Li-Juan Deng et al.

Summary: Abnormal N6-methyladenosine (m6A) modification is closely related to cancer development, and finding targeted anticancer drugs is important. Traditional herbs and computer-synthesized compounds are reasonable sources for these drugs. Artificial intelligence has advantages in discovering m6A-targeting anticancer drugs.

MOLECULAR CANCER (2022)

Article Critical Care Medicine

Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo- controlled, phase atrial

Aurelien Mazeraud et al.

Summary: In patients with moderate-to-severe ARDS caused by COVID-19 and receiving invasive mechanical ventilation, IVIG did not improve clinical outcomes at day 28 and may be associated with an increased frequency of serious adverse events. The effect of IVIGs on earlier stages of COVID-19 should be assessed in future trials.

LANCET RESPIRATORY MEDICINE (2022)

Article Biotechnology & Applied Microbiology

N6-methyladenosine reader YTH N6-methyladenosine RNA binding protein 3 or insulin like growth factor 2 mRNA binding protein 2 knockdown protects human bronchial epithelial cells from hypoxia/reoxygenation injury by inactivating p38 MAPK, AKT, ERK1/2, and NF-κB pathways

Kun Xiao et al.

Summary: In this study, the authors found that YTHDF3 and IGF2BP2 were dysregulated in lung ischemia/reperfusion injury (LIRI), and their knockdown could attenuate hypoxia/reoxygenation-induced cell injury and inflammatory response. Analysis revealed that knocking down YTHDF3 or IGF2BP2 affected a series of signaling pathways, including p38, AKT, ERK1/2, and NF-kappa B. These findings highlight the importance of m6A-related regulators in LIRI.

BIOENGINEERED (2022)

Article Public, Environmental & Occupational Health

Clinical Evidence Informing Treatment Guidelines on Repurposed Drugs for Hospitalized Patients During the Early COVID-19 Pandemic: Corticosteroids, Anticoagulants, (Hydroxy)chloroquine

Stefanie Wuestner et al.

Summary: This study analyzed the development of global evidence on repurposed drugs for hospitalized COVID-19 patients, focusing on corticosteroids, anticoagulants, and (hydroxy)chloroquine. The study found that early evidence was of low quality, but as the pandemic progressed, larger and more rigorous studies provided better clinical evidence supporting treatment recommendations. Multi-arm platform trials and coordinated meta-analyses were particularly successful in generating timely and robust evidence.

FRONTIERS IN PUBLIC HEALTH (2022)

Review Pharmacology & Pharmacy

Thromboinflammation in coronavirus disease 2019: The clot thickens

Raayma Iffah et al.

Summary: The pathophysiology of COVID-19 is complex, with multiple systems contributing to thrombosis and inflammation. Understanding the role of the immune system in different patient cohorts is crucial for developing novel therapeutic targets and drug repurposing strategies.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Biotechnology & Applied Microbiology

The effect of N6-methyladenosine (m6A) factors on the development of acute respiratory distress syndrome in the mouse model

Liming Fei et al.

Summary: The study found that the levels of m6A-RNA methylation were altered in a lipopolysaccharide (LPS)-induced acute respiratory distress syndrome (ARDS) mouse model. m6A methylation may be involved in the expression regulation of inflammatory factors in lung tissue and play important roles in the occurrence and development of ARDS.

BIOENGINEERED (2022)

Article Immunology

METTL3-Mediated N6-Methyladenosine Modification of Trim59 mRNA Protects Against Sepsis-Induced Acute Respiratory Distress Syndrome

Yi Chen et al.

Summary: The levels of m(6)A RNA modification are decreased in septic lungs, with METTL3 as the main regulator involved. METTL3 regulates endothelial injury in sepsis-induced ARDS through Trim59-associated NF-kappa B inactivation. These findings have important implications for the diagnosis and treatment of sepsis-induced ARDS.

FRONTIERS IN IMMUNOLOGY (2022)

Review Genetics & Heredity

m6A Methylation in Cardiovascular Diseases: From Mechanisms to Therapeutic Potential

Longbo Li et al.

Summary: Cardiovascular disease (CVD) is a major global health problem, and recent studies have shown that n6-methyladenosine (m6A) plays a significant role in cardiovascular homeostasis and pathophysiology. m6A methylation affects the pathophysiology of CVD by regulating cellular processes such as differentiation, proliferation, inflammation, autophagy, and apoptosis. Post-transcriptional regulation of RNA through m6A modification has been found to delay the progression of CVD. However, there is a lack of available summaries on m6A modification regarding CVD. This review highlights the advancements in CVD-specific research on m6A modification, summarizes the mechanisms underlying the involvement of m6A modification in CVD development, and discusses the potential of m6A modification as a therapeutic target for CVD.

FRONTIERS IN GENETICS (2022)

Article Environmental Sciences

Methyltransferase-like 3 leads to lung injury by up-regulation of interleukin 24 through N6-methyladenosine-dependent mRNA stability and translation efficiency in mice exposed to fine particulate matter 2.5

Xiang He et al.

Summary: This study reveals the significant role of m6A modification in lung injury caused by PM2.5 exposure. The findings suggest that PM2.5 exposure increases the total level of m6A modification and the expression of METTL3. This upregulation of METTL3 leads to increased expression and m6A modification of IL24, enhancing the stability of IL24 mRNA. Additionally, PM2.5 exposure also upregulates the expression of YTHDF1, which augments the translation efficiency of IL24 mRNA. Downregulation of Mettl3 reduces IL24 expression and improves pulmonary inflammation and mucus secretion in PM2.5-exposed mice.

ENVIRONMENTAL POLLUTION (2022)

Article Cell Biology

Neutrophil extracellular traps-triggered impaired autophagic flux via METTL3 underlies sepsis-associated acute lung injury

Mengdi Qu et al.

Summary: The level of neutrophil extracellular traps (NETs) is increased in ARDS patients and mice models, leading to impaired autophagic flux and disease deterioration. NETs activate METTL3 mediated m(6)A methylation of Sirt1 mRNA, which further enhances abnormal autophagy.

CELL DEATH DISCOVERY (2022)

Article Critical Care Medicine

The Epidemiology of Acute Respiratory Distress Syndrome Before and After Coronavirus Disease 2019

Kathryn W. Hendrickson et al.

CRITICAL CARE CLINICS (2021)

Review Pharmacology & Pharmacy

COVID-related fibrosis: insights into potential drug targets

Giacomo Sgalla et al.

Summary: The use of antifibrotic therapies in COVID-19-related lung fibrosis is promising, but uncertainties remain regarding the timing and risks/benefits ratio of treatment intervention. Ongoing clinical trials and long-term observations will clarify the best management approach for these patients.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)

Article Neurosciences

METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer's disease through aberrant cell cycle events

Fanpeng Zhao et al.

Summary: The study revealed that decreased m(6)A levels and reduced expression of METTL3 in AD brains led to memory deficits, synaptic loss, neuronal death, and multiple cellular alterations. Restoring m(6)A modification by inhibiting demethylation or overexpressing METTL3 rescued synaptic damage, cognitive impairment, and neuronal deficits in AD models.

MOLECULAR NEURODEGENERATION (2021)

Editorial Material Oncology

m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis

Dan Jin et al.

Summary: The study demonstrated that METTL3 promotes YAP mRNA translation by increasing m(6)A modification, and enhances YAP mRNA stability through regulating the MALAT1-miR-1914-3p-YAP axis, leading to the promotion of invasion and metastasis in NSCLC.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Multidisciplinary Sciences

METTL3-dependent N6-methyladenosine RNA modification mediates the atherogenic inflammatory cascades in vascular endothelium

Chian-Shiu Chien et al.

Summary: The study identified the important role of N-6-methyladenosine (m(6)A) RNA methylation in mechanotransduction in endothelial cells, with METTL3 as a central player in response to hemodynamic forces and atherogenic stimuli. The METTL3-mediated RNA hypermethylation regulated up-regulation of the NLRP1 transcript and downregulation of the KLF4 transcript through the YTHDF1 and YTHDF2 m(6)A reader proteins. Knockdown of METTL3 via repetitive shRNA administration prevented the atherogenic process, NLRP3 up-regulation, and KLF4 down-regulation in an in vivo atherosclerosis model.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Review Oncology

The Impact of m6A RNA Modification in Therapy Resistance of Cancer: Implication in Chemotherapy, Radiotherapy, and Immunotherapy

Omprakash Shriwas et al.

Summary: m6A RNA methylation plays a critical role in regulating oncogene expression and tumor progression. While its potential role in cancer cell proliferation has been well documented, further research is needed to understand its involvement in the development of therapy resistance in cancer.

FRONTIERS IN ONCOLOGY (2021)

Article Multidisciplinary Sciences

METTL14 facilitates global genome repair and suppresses skin tumorigenesis

Zizhao Yang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Review Immunology

The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer

Xinwei Xu et al.

Summary: Methylation is a significant epigenetic modification found in both DNAs and RNAs, playing crucial roles in various cancers, especially colorectal cancer. The m6A modification regulates RNA and immune cells, affecting intestinal mucosal immunity and the development of inflammatory bowel disease and colorectal cancer. m6A-related genes and factors may serve as potential predictive markers and therapeutic targets.

JOURNAL OF INFLAMMATION RESEARCH (2021)

Article Respiratory System

The role of RNA m6A methylation in the regulation of postnatal hypoxia-induced pulmonary hypertension

Shanshan Xu et al.

Summary: The study revealed that postnatal exposure to hypoxia can lead to pulmonary hypertension (PH) which may persist into adulthood. The m6A modification plays a crucial role in the development of PH, with its level changes potentially affecting the expression of PH-related genes and lung development.

RESPIRATORY RESEARCH (2021)

Article Biotechnology & Applied Microbiology

Predicting candidate therapeutic drugs for sepsis-induced acute respiratory distress syndrome based on transcriptome profiling

Jiawei Ma et al.

Summary: This study utilized gene expression data to predict druggable targets for sepsis-induced ARDS, identifying potential therapeutic drug candidates and suggesting doxorubicin as a potential treatment targeting TOP2A.

BIOENGINEERED (2021)

Article Medicine, General & Internal

Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Final Report

Jennifer E. Layden et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Cardiac & Cardiovascular Systems

COVID-19 and heart failure: from infection to inflammation and angiotensinIIstimulation. Searching for evidence from a new disease

Daniela Tomasoni et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

Review Pharmacology & Pharmacy

Severe Acute Lung Injury Related to COVID-19 Infection: A Review and the Possible Role for Escin

Luca Gallelli et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Microbiology

Convalescent Plasma Therapy for COVID-19: State of the Art

Daniele Focosi et al.

CLINICAL MICROBIOLOGY REVIEWS (2020)

Article Biochemistry & Molecular Biology

A Unified Model for the Function of YTHDF Proteins in Regulating m6A-Modified mRNA

Sara Zaccara et al.

Article Gastroenterology & Hepatology

A New Model of Spontaneous Colitis in Mice Induced by Deletion of an RNA m(6)A Methyltransferase Component METTL14 in T Cells

Thomas X. Lu et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Genetics & Heredity

SARS-CoV-2 genomic variations associated with mortality rate of COVID-19

Yujiro Toyoshima et al.

JOURNAL OF HUMAN GENETICS (2020)

Editorial Material Medicine, General & Internal

Covid-19: The inside story of the RECOVERY trial

Jacqui Wise et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Biochemistry & Molecular Biology

FTO controls reversible m6Am RNA methylation during snRNA biogenesis

Jan Mauer et al.

NATURE CHEMICAL BIOLOGY (2019)

Review Biochemistry & Molecular Biology

Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers

Hailing Shi et al.

MOLECULAR CELL (2019)

Article Cell Biology

The RNA N6-methyladenosine modification landscape of human fetal tissues

Shan Xiao et al.

NATURE CELL BIOLOGY (2019)

Article Multidisciplinary Sciences

Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation

Huamin Wang et al.

NATURE COMMUNICATIONS (2019)

Article Biochemistry & Molecular Biology

Molecular characterization and clinical relevance of m6A regulators across 33 cancer types

Yongsheng Li et al.

MOLECULAR CANCER (2019)

Letter Medicine, General & Internal

Real-Time Digital Surveillance of Vaping-Induced Pulmonary Disease

Yulin Hswen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Oncology

RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer

Mingxia Yan et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Cardiac & Cardiovascular Systems

The N6-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy

Lisa E. Dorn et al.

CIRCULATION (2019)

Article Oncology

The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells

Kosuke Taketo et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2018)

Review Cardiac & Cardiovascular Systems

Epidemiology of cardiovascular disease in young individuals

Charlotte Andersson et al.

NATURE REVIEWS CARDIOLOGY (2018)

Article Biochemistry & Molecular Biology

Differential m(6)A, m(6)A(m), and m(1)A Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm

Jiangbo Wei et al.

MOLECULAR CELL (2018)

Article Multidisciplinary Sciences

m6A facilitates hippocampus-dependent learning and memory through YTHDF1

Hailing Shi et al.

NATURE (2018)

Article Multidisciplinary Sciences

Reversible methylation of m6Am in the 5′ cap controls mRNA stability

Jan Mauer et al.

NATURE (2017)

Article Respiratory System

Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure

Bram Rochwerg et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Article Multidisciplinary Sciences

Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control

Isaia Barbieri et al.

NATURE (2017)

Review Medicine, General & Internal

Acute Respiratory Distress Syndrome

B. Taylor Thompson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Cardiac & Cardiovascular Systems

Reducing the Global Burden of Cardiovascular Disease, Part 2 Prevention and Treatment of Cardiovascular Disease

Darryl P. Leong et al.

CIRCULATION RESEARCH (2017)

Article Biochemistry & Molecular Biology

The U6 snRNA m6A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention

Kathryn E. Pendleton et al.

Review Physiology

Endothelial cell signaling and ventilator-induced lung injury: molecular mechanisms, genomic analyses, and therapeutic targets

Ting Wang et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2017)

Review Critical Care Medicine

The Epidemiology of Acute Respiratory Distress Syndrome A 50th Birthday Review

Tai Pham et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)

Article Multidisciplinary Sciences

m6A RNA methylation promotes XIST-mediated transcriptional repression

Deepak P. Patil et al.

NATURE (2016)

Article Critical Care Medicine

The Association between Acute Respiratory Distress Syndrome, Delirium, and In-Hospital Mortality in Intensive Care Unit Patients

S. Jean Hsieh et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Article Biochemistry & Molecular Biology

5′ UTR m6A Promotes Cap-Independent Translation

Kate D. Meyer et al.

Article Cell & Tissue Engineering

m6A RNA Modification Controls Cell Fate Transition in Mammalian Embryonic Stem Cells

Pedro J. Batista et al.

CELL STEM CELL (2014)

Article Biochemistry & Molecular Biology

A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation

Jianzhao Liu et al.

NATURE CHEMICAL BIOLOGY (2014)

Article Medicine, General & Internal

Rosuvastatin for Sepsis-Associated Acute Respiratory Distress Syndrome

Jonathon D. Truwit et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Critical Care Medicine

β2 Agonist for the Treatment of Acute Lung Injury: A Systematic Review and Meta-analysis

Balwinder Singh et al.

RESPIRATORY CARE (2014)

Review Toxicology

Alcoholic lung injury: Metabolic, biochemical and immunological aspects

Lata Kaphalia et al.

TOXICOLOGY LETTERS (2013)

Review Genetics & Heredity

Reversible RNA adenosine methylation in biological regulation

Guifang Jia et al.

TRENDS IN GENETICS (2013)

Article Critical Care Medicine

Mechanical stress induces lung fibrosis by epithelial-mesenchymal transition

Nuria E. Cabrera-Benitez et al.

CRITICAL CARE MEDICINE (2012)

Article Critical Care Medicine

The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material

Niall D. Ferguson et al.

INTENSIVE CARE MEDICINE (2012)

Article Medicine, General & Internal

Acute Respiratory Distress Syndrome The Berlin Definition

V. Marco Ranieri et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

Article Critical Care Medicine

A Randomized Clinical Trial of Hydroxymethylglutaryl-Coenzyme A Reductase Inhibition for Acute Lung Injury (The HARP Study)

Thelma R. Craig et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Critical Care Medicine

The Future of Exogenous Surfactant Therapy

Douglas F. Willson et al.

RESPIRATORY CARE (2011)

Review Respiratory System

Corticosteroids and ARDS: A review of treatment and prevention evidence

G. C. Khilnani et al.

LUNG INDIA (2011)

Article Critical Care Medicine

Recent trends in acute lung injury mortality: 1996-2005

Sara E. Erickson et al.

CRITICAL CARE MEDICINE (2009)

Review Oncology

5-Fluorouracil: Mechanisms of action and clinical strategies

DB Longley et al.

NATURE REVIEWS CANCER (2003)